Tereza Popkova
Ostrava, MO, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Teclistamab in relapsed/refractory Waldenström macroglobulinemia
Journal: Haematologica
Published: April 28, 2026
Treatment Patterns and Outcomes in Over 2200 Newly Diagnosed Multiple Myeloma Patients: Supporting Bortezomib-Lenalidomide-Dexamethasone as a Preferred Regimen in the Absence of Anti-CD38 Antibodies.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 10, 2025
Composition and Functional State of T and NK Cells in the Extramedullary Myeloma Tumor Microenvironment.
Journal: Blood cancer discovery
Published: May 15, 2025
Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs.
Journal: Blood
Published: April 14, 2025
Selective depletion of B-cell subsets underlies increased risk of infection in MM patients treated with anti-BCMA vs -GPRC5D bsAbs.
Journal: Blood
Published: April 14, 2025
Level of Clonal Plasma Cells in Hematopoietic Cell Autografts Reflects the Pre-Transplant Bone Marrow Minimal Residual Disease in Multiple Myeloma Patients.
Journal: American journal of hematology
Published: November 04, 2024
One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID-19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic.
Journal: Cancer medicine
Published: October 07, 2024
Real-World Evidence on Prognostic Value of MRD in Multiple Myeloma Using Flow Cytometry.
Journal: European journal of haematology
Published: August 08, 2024
Last Updated: 09/26/2026